Cadila Healthcare is currently trading at Rs. 680.90, up by 17.85 points or 2.69% from its previous closing of Rs. 663.05 on the BSE.
The scrip opened at Rs. 668.95 and has touched a high and low of Rs. 685.00 and Rs. 666.50 respectively. So far 13002 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 924.60 on 22-Feb-2013 and a 52 week low of Rs. 631.00 on 20-Aug-2013.
Last one week high and low of the scrip stood at Rs. 692.20 and Rs. 650.00 respectively. The current market cap of the company is Rs. 13870.69 crore.
The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 14.71% and 10.50% respectively.
Cadila Healthcare has reported results for the second quarter ended September 30, 2013.
The company has reported 81.57% rise in its net profit at Rs 151.76 crore for the quarter as compared to Rs 83.58 crore for the same quarter in the previous year. Total income of the company has increased by 10.72% at Rs 993.69 crore for quarter under review as compared to Rs 897.41 crore for the quarter ended September 30, 2012.
On the consolidated basis, the group has registered a growth of 93.75% in net profit after taxes, minority interest and share of profit / (loss) of associates at Rs 183.37 crore as compared to Rs 94.64 crore in the same quarter previous year. Total income of the group rose 13.18% to Rs 1759.02 crore for quarter under review as against Rs 1554.10 crore in corresponding quarter previous year.
Source:- berkeleygains
The scrip opened at Rs. 668.95 and has touched a high and low of Rs. 685.00 and Rs. 666.50 respectively. So far 13002 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 924.60 on 22-Feb-2013 and a 52 week low of Rs. 631.00 on 20-Aug-2013.
Last one week high and low of the scrip stood at Rs. 692.20 and Rs. 650.00 respectively. The current market cap of the company is Rs. 13870.69 crore.
The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 14.71% and 10.50% respectively.
Cadila Healthcare has reported results for the second quarter ended September 30, 2013.
The company has reported 81.57% rise in its net profit at Rs 151.76 crore for the quarter as compared to Rs 83.58 crore for the same quarter in the previous year. Total income of the company has increased by 10.72% at Rs 993.69 crore for quarter under review as compared to Rs 897.41 crore for the quarter ended September 30, 2012.
On the consolidated basis, the group has registered a growth of 93.75% in net profit after taxes, minority interest and share of profit / (loss) of associates at Rs 183.37 crore as compared to Rs 94.64 crore in the same quarter previous year. Total income of the group rose 13.18% to Rs 1759.02 crore for quarter under review as against Rs 1554.10 crore in corresponding quarter previous year.
Source:- berkeleygains